-+ 0.00%
-+ 0.00%
-+ 0.00%

LIPOCINE ANNOUNCES HEALTH CANADA APPROVAL OF TLANDO® FOR TESTOSTERONE REPLACEMENT THERAPY

Reuters·10/07/2026 12:02:24